2BBBullish & Bearish
Smith & Nephew SNATS, Inc. Common Stock (SNN) trades on NYSE. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 30 out of 100.
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Smith & Nephew SNATS, Inc. Common Stock’s current 2BB score is 30 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 0 | Very Low |
| CEO | Deepak Nath |
| Founded | 1856 |
| Employees | 17K |
| P/E ratio | 20.31 |
| 52-week range | $28.56 – $38.79 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | — | — | — |
| 2026-08-04 | — | — | — | — |
| 2026-05-06 | — | — | — | — |
| 2026-03-02 | — | — | — | — |